Ampio Pharmaceuticals, Inc.
(NYSE Amex Equities : AMPE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. 3.03%61.940.0%$779.50m
VRXValeant Pharmaceuticals International, Inc. -2.07%28.8614.1%$169.82m
CTLTCatalent, Inc. 0.28%141.412.0%$168.28m
PRGOPerrigo Co. Plc 0.55%43.016.9%$140.02m
ICLRICON plc 0.56%283.042.8%$122.12m
HZNPHorizon Therapeutics Plc 0.80%110.375.5%$106.97m
JAZZJazz Pharmaceuticals Plc 0.63%135.352.1%$104.94m
INDPIndaptus Therapeutics, Inc. -6.86%8.820.0%$101.49m
ARGXargenx SE -3.15%308.000.0%$64.03m
BHCBausch Health Cos., Inc. -2.07%28.860.0%$60.89m
ENDPEndo International Plc -3.85%3.258.5%$56.03m
UTHRUnited Therapeutics Corp. -2.68%195.1014.0%$46.59m
AXSMAxsome Therapeutics, Inc. 1.34%33.401.8%$38.98m
IRWDIronwood Pharmaceuticals, Inc. 3.54%13.459.5%$24.56m
SAGESAGE Therapeutics, Inc. -1.69%45.427.6%$21.56m

Company Profile

Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Englewood, CO.